Market research
V4TA.F Vectura Group plc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1B
- P/E ratio
- 8.32
- Analyst target
- 173.4
- Dividend yield
- 22.%
- Beta
- 0.45
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- ISIN
- Not available
- Market cap
- 1B
- P/E ratio
- 8.32
- Analyst target
- 173.4
- Dividend yield
- 22.%
- Beta
- 0.45
About
About Vectura Group plc
Vectura Group plc engages in the development of pharmaceutical therapies for the treatment of airways-related diseases. Vectura Group plc was formerly known as Vectura Limited and changed its name to Vectura Group plc in June 2004. The company was incorporated in 1997 and is based in Wiltshire, United Kingdom. As of October 19, 2021, Vectura Group plc operates as a subsidiary of PMI Global Services, Inc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the V4TA.F discussion.
5 years, 6 months ago
Vectura Group plc is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Finally, its free cash flow fell by 67.1% to $3M since the same quarter in the previous year.
Based on the above factors, Vectura Group plc gets an overall score of 2/5.